Naxos disease: Cardiocutaneous syndrome due to cell adhesion defect

Orphanet Journal of Rare Diseases

Volumn 1, Issue 1, 2006, Pages

  Protonotarios, Nikos ^a   Tsatsopoulou, Adalena ^a  

^a Yannis Protonotarios Medical Center   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE;

EID: 34248184670     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-1-4     Document Type: Review

References (31)

1. Cardiac abnormalities in familial palmoplantar keratosis. N Protonotarios A Tsatsopoulou P Patsourakos D Alexopoulos P Gezerlis S Simitsis G Scampardonis, Br Heart J 1986 56 321 326 2945574
2. Right ventricular cardiomyopathy and sudden death in young people. N Protonotarios A Tsatsopoulou G Scampardonis, N Engl J Med 1988 319 175
3. Comparisons between Naxos disease and arrhythmogenic right ventricular dysplasia by electrocardiography and biopsy. G Fontaine N Protonotarios A Tsatsopoulou R Tsezana F Fontaliran R Frank, Circulation 1994 90 3233
4. Arrhythmogenic right ventricular cardiomyopathy. Clinical forms of the disease. N Protonotarios A Tsatsopoulou, Hellenic J Cardiol 1998 39 Suppl A 78 80
5. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. P Richardson W McKenna M Bristow B Maisch B Mautner J O'Connell E Olsen G Thiene J Goodwin I Gyarfas I Martin P Nordet, Circulation 1996 93 841 842 8598070
6. Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. N Protonotarios A Tsatsopoulou, Cardiovasc Path 2004 13 185 194 10.1016/j.carpath.2004.03.609
7. Arrhythmogenic right ventricular cardiomyopathy (Naxos disease): report of a Turkish boy. N Narin M Akcakus T Gunes A Celiker A Baykan K Uzum A Ferahbas, Pacing Clin Electrophysiol 2003 26 2326 2329 10.1111/j.1540-8159.2003. 00370.x 14675023
8. Evidence for extensive locus heterogeneity in Naxos disease. K Djabali A Martinez-Mir L Horev AM Christiano A Zlotogorski, J Invest Dermatol 2002 118 557 560 10.1046/j.0022-202x.2001.01627.x 11874502
9. Naxos disease in Saudi Arabia. I Bukhari N Juma'a, J Eur Acad Dermatol Venereol 2004 18 614 616 10.1111/j.1468-3083.2004.01010.x 15324409
10. Familial occurrence of a rare combination of dilated cardiomyopathy with palmoplantar keratoderma and woolly hair. BH Rao IS Reddy KS Chandra, Indian Heart J 1996 48 161 162 8682558
11. pidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. L Carvajal-Huerta, J Am Acad Dermatol 1998 39 E418 421 10.1016/S0190-9622(98)70317-2
12. Naxos disease: Keratoderma, scalp modifications, and cardiomyopathy. N Protonotarios A Tsatsopoulou G Fontaine, J Am Acad Dermatol 2001 44 309 310 10.1067/mjd.2001.110648 11174397
13. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. AS Coonar N Protonotarios A Tsatsopoulou EW Needham RS Houlston S Cliff MI Otter VA Murday RK Mattu WJ McKenna, Circulation 1998 97 2049 2058 9610536
14. Genotype-phenotype assessment in autosomal recessive arrhythmogenic right ventricular cardiomyopathy (Naxos disease) caused by a deletion in plakoglobin. N Protonotarios A Tsatsopoulou A Anastasakis E Sevdalis G McKoy K Stratos K Gatzoulis K Tentolouris C Spiliopoulou D Panagiotakos W McKenna P Toutouzas, J Am Coll Cardiol 2001 38 1477 1484 10.1016/S0735-1097(01)01568-6 11691526
15. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group on Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. WJ McKenna G Thiene A Nava F Fontaliran C Blomstrom-Lundqvist G Fontaine F Camerini, Br Heart J 1994 71 215 218 8142187
16. Arrhythmogenic right ventricular cardiomyopathy caused by a deletion in plakoglobin (Naxos disease). N Protonotarios A Tsatsopoulou K Gatzoulis, Card Electrophysiol Rev 2002 6 72 80 10.1023/A:1017943323473 11984022
17. Structural and molecular pathology of the heart in Carvajal syndrome. SR Kaplan JJ Gard L Carvajal-Huerta JC Ruiz-Cabezas G Thiene JE Saffitz, Cardiovasc Pathol 2004 13 26 32 10.1016/S1054-8807(03)00107-8 14761782
18. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). G McKoy N Protonotarios A Crosby A Tsatsopoulou A Anastasakis A Coonar M Norman C Baboonian S Jeffery WJ McKenna, Lancet 2000 355 2119 2124 10.1016/S0140-6736(00)02379-5 10902626
19. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. EE Norgett SJ Hatsell L Carvajal-Huerta JC Cabezas J Common PE Purkis N Whittock IM Leigh HP Stevens DP Kelsell, Hum Molec Genet 2000 9 2761 2766 10.1093/hmg/9.18.2761 11063735
20. A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder, and woolly hair. R Alcalai S Metzger S Rosenheck V Meiner T Chajek-Shaul, J Am Coll Cardiol 2003 42 319 327 10.1016/S0735-1097(03)00628-4 12875771
21. Dilated cardiomyopathy: a disease of the intercalated disc? JC Perriard A Hirschy E Ehler, Trends Cardiovasc Med 2003 13 30 38 10.1016/S1050-1738(02) 00209-8 12554098
22. The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. S Kanno JE Saffitz, Cardiovasc Pathol 2001 10 169 177 10.1016/S1054-8807(01)00078-3 11600334
23. Plakoglobin and β-catenin: protein interactions, regulation and biological role. J Zhurinsky M Shtutman A Ben-Ze'ev, J Cell Sci 2000 113 3127 3139 10954412
24. Cross-talk between adherens junctions and desmosomes depends on plakoglobin. JE Lewis JK Wahl III KM Sass PJ Jensen KR Johnson MJ Wheelock, J Cell Biol 1997 136 919 934 10.1083/jcb.136.4.919 9049256
25. Proteolytic processing of the adherens junctions components β-catenin and γ-catenin/plakoglobin during apoptosis. C Brancolini A Sgorbissa C Schneider, Cell Death Differ 1998 5 1042 1050 10.1038/sj.cdd.4400443 9894611
26. Arrhythmogenic right ventricular dysplasia. G Fontaine F Fontaliran JL Hebert D Chemla O Zenati Y Lecarpentier R Frank, Ann Rev Med 1999 50 17 35 10.1146/annurev.med.50.1.17 10073261
27. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). SR Kaplan JJ Gard N Protonotarios A Tsatsopoulou C Spiliopoulou A Anastasakis CP Squarcioni WJ McKenna G Thiene C Basso N Brousse G Fontaine JE Saffitz, Heart Rhythm 2004 1 3 11 10.1016/j.hrthm.2004.01.001 15851108
28. Implantable defibrillator therapy in Naxos disease. K Gatzoulis N Protonotarios A Anastasakis A Tsatsopoulou J Vlasseros J Gialafos P Toutouzas, Pacing Clin Electrophysiol 2000 23 1176 1178 10914377
29. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. D Corrado L Leoni MS Link P Della Bella F Gaita A Curnis JU Salerno D Igidbashian A Raviele M Disertori G Zanotto R Verlato G Vergara P Delise P Turrini C Basso F Naccarella F Maddalena NA Estes 3rd G Buja G Thiene, Circulation 2003 108 3084 3091 10.1161/01.CIR.0000103130.33451.D2 14638546
30. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. T Wichter M Borggrefe W Haverkamp X Chen G Breithardt, Circulation 1992 86 29 37 1617780
31. Arrhythmogenic right ventricular cardiomyopathy: clinical registry and database, evaluation of therapies, pathology registry, DNA banking. C Basso T Wichter GA Danieli D Corrado E Czarnowska G Fontaine WJ McKenna A Nava N Protonotarios L Antoniades K Wlodarska F D'Alessi G Thiene, Eur Heart J 2004 25 531 534 10.1016/j.ehj.2003.12.025 15039134